Acellmed took part in the second edition of the nationwide Health Business Innovations conference, devoted to broadly understood health care, on June 22 this year in Zabrze. This very significant event in the field of bio-med-tech-biz attracted over 200 people, including entrepreneurs, scientists, medics, and local government officials. Participants of HBI 2023 had the opportunity…
We are pleased to announce that Acellmed was among 151 innovative medical startups from Poland and the CEE region, presented in the “Top Disruptors in Healthcare” Report. The results of the Report were announced on June 6 this year during the AI & MEDTECH CEE conference. This report aims to present innovative medical startups, their…
3rd National Scientific Conference “InnWet – innovative sides of modern veterinary medicine and zoology” took place on May 24 this year. Issues associated with animals’ health and treatment, their nutrition, biotechnology and behaviorism were main topics during the event. We are pleased to announce that representatives of our team, Joanna Tunikowska, DVSc. (Wrocław University of…
On May 12 – 13, 2023, the 5th International Conference “Innovations in Ophthalmology” was held in Katowice. During the Conference, Acellmed together with researchers from the Silesian Park of Medical Technology Kardio-Med Silesia presented a poster entitled “An innovative method of producing a hydrogel dressing for autologous limbal cell transplantation in the treatment of limbal…
On March 2-4, 2023, the International Conference “Innovations in Ophthalmology” was held in Katowice, where the latest achievements of modern world ophthalmology were presented as part of a series of meetings. Acellmed also with researchers from the Silesian Park of Medical Technologies Kardio-Med Silesia presented a poster on “The possibilities of tissue engineering in the…
We are pleased to inform you that Acellmed and its corneal project have been noticed in #HuaweiStartupChallenge3, organized by @Huawei Polska and @Startup Academy. After successfully passing the first two stages of the competition, we are among 20 finalists – the best Polish startups (selected out of 168!). Congrats to other startups who qualified for…
On December 2, during a meeting at the Silesian Center for Entrepreneurship, Acellmed received a distinction as a LEADER OF CHANGE in the medical category. Five companies were awarded, including ACM as the only company in this category.
…
We are pleased to announce that on 08/11/2022 a Scientific Cooperation Agreement was signed between the M. Skłodowska-Curie National Research Institute of Oncology Gliwice Branch and the consortium: Acellmed Sp. z o.o. and Silesian Park of Medical Technology Kardio-Med Silesia. The scientific cooperation will consist in verifying the therapeutic activity and specificity of action of the anti-acute myeloid leukemia (AML) drug being developed by the Acellmed – ŚPTM Kardio-Med Silesia consortium on leukemic cells of AML patients being treated at the M. Skłodowska-Curie National Research Institute of Oncology Gliwice Branch.
…
Nearly 150 applications were submitted to the prestigious Start-up Challenge 2022 competition, organized within the framework of 14th European Economic Congress. As a result, the most interesting start-ups, divided into five contest categories, were selected. The best 15, who qualified for the semi-finals, presented their work to a broad audience during the European Economic Congress,…
We are pleased to announce that Acellmed has been qualified as one of the 15 start-ups to the semi-finals of the Start-up Challenge 2022 competition and will be presented during the XIV European Economic Congress on 25-27.04.2022. We will present our company in the category HEALTH & BIOTECHNOLOGY – Medicine, health, medical technology, pharmacy, biotechnology.…
